Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kits EyecareKTYCF -0.08%74 Debt-to-EBITDA is 0.32 as of Mar. 2026, which is 79% below its 10-year median of 1.52. GuruFocus rates KTYCF with a GF Score™ of 74/100 and a GF Value™ of $9.64 (Fairly Valued). The stock has 1 warning sign investors should review. Among 901 Retail - Cyclical companies, Kits Eyecare ranks better than 86.24% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Kits Eyecare's Debt-to-EBITDA or its related term are showing as below:
KTYCF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -26.96 Med: 1.52 Max: 8.29
Current: 0.6
During the past 8 years, the highest Debt-to-EBITDA Ratio of Kits Eyecare was 8.29. The lowest was -26.96. And the median was 1.52.
KTYCF's Debt-to-EBITDA is ranked better than 86.24% of 901
companies
in the Retail - Cyclical industry
Industry Median: 2.4
vs KTYCF: 0.60
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Kits Eyecare Debt-to-EBITDA Related Terms
Kits Eyecare Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Kits Eyecare's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KTYCF vs CASY, WSM, DKS: Debt-to-EBITDA Comparison
For the Specialty Retail subindustry, Kits Eyecare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kits Eyecare Debt-to-EBITDA vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Kits Eyecare's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Kits Eyecare's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Kits Eyecare (KTYCF) has a Debt-to-EBITDA of 0.32 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Kits Eyecare. This is 79% below median its historical median of 1.52. According to the industry distribution chart, Kits Eyecare ranks #124 out of 901 companies in the Retail - Cyclical industry, placing it in the top 13.8%.
Is Kits Eyecare's Debt-to-EBITDA too high?
Kits Eyecare's current Debt-to-EBITDA of 0.32 is 79% below median its 10-year median of 1.52. The Retail - Cyclical industry median Debt-to-EBITDA is 2.40. Kits Eyecare's value of 0.32 is 86.7% below this industry median. Based on the distribution chart, Kits Eyecare ranks #124 out of 901 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Kits Eyecare has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's Debt-to-EBITDA compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Kits Eyecare ranks #124 out of 901 companies for Debt-to-EBITDA. This places Kits Eyecare in the top 14% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.40. Kits Eyecare's value of 0.32 is 86.7% below this benchmark. While the company's 10-year median is 1.52 vs. the industry median of 2.40, Kits Eyecare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Retail - Cyclical company?
The median Debt-to-EBITDA among Retail - Cyclical companies is 2.40, based on 901 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kits Eyecare's current Debt-to-EBITDA of 0.32 is 86.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Kits Eyecare. For the Retail - Cyclical industry, the median Debt-to-EBITDA is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kits Eyecare's current Debt-to-EBITDA is 0.32, which is 79% below median its own 10-year median of 1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (KTYCF) is currently considered Fairly Valued. The stock's GF Value™ is $9.64, compared to a current price of $9.51 — trading 1.3% below its estimated fair value. The current Debt-to-EBITDA is 0.32, which is 79% below median its 10-year median of 1.52 and 86.7% below the Retail - Cyclical industry median of 2.40. Kits Eyecare's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Kits Eyecare (KTYCF), the current Debt-to-EBITDA is 0.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kits Eyecare (KTYCF) Overvalued in 2026?
Based on GuruFocus' analysis, Kits Eyecare stock appears to be undervalued.
The current stock price of $9.51 is trading 1.3% below its estimated GF Value™ of $9.64.
GuruFocus considers Kits Eyecare to be Fairly Valued.
Key valuation signals for KTYCF:
Debt-to-EBITDA: 0.32 (79% below median its 10-year median of 1.52)
GF Value™: $9.64 vs. price of $9.51 (1.3% below fair value)
Industry Position: 86.7% below the Retail - Cyclical median (#124 of 901)
No single metric tells the full story. See the KTYCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
74GF Score
Get the complete analysis for KTYCF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KTYCF has been successfully added to your 
